Literature DB >> 28812237

Pharmacological Effects on Ceroid Lipofuscin and Neuronal Structure in Cln3 ∆ex7/8 Mouse Brain Cultures.

Douglas E Brenneman1, David A Pearce2,3, Attila Kovacs2,3, Shawn DeFrees4.   

Abstract

Juvenile Batten disease (JBD) is an inherited disorder that is characterized by the development of blindness, seizures, and progressive motor, psychiatric, and cognitive impairment. A model of JBD expressing the predominant human mutation (Cln3 ∆ex7/8 ) has been explored. Dissociated brain cultures from Cln3 ∆ex7/8 knock-in mice were compared to wild type (WT) for effects on granules of ceroid lipofuscin (CL) and neuronal structure. Utilizing high content image analysis of CL granules identified with antibodies to mitochondrial ATP synthase subunit c or tripeptidyl peptidase-1, significant increases in the areas for both immunoreactive granules were observed in Cln3 ∆ex7/8 cultures in comparison to WT. CL granules also exhibit autofluorescence at 488 and 560 nm, and the areas of these autofluorescent spots were found to be significantly increased in Cln3 ∆ex7/8 cultures in comparison to WT. Progressive increases in CL granule area in Cln3 ∆ex7/8 cultures were observed during culture development. Because current therapies for JBD provide only symptomatic support, a therapeutic strategy has been explored based on the observations that JBD-related tissues are deficient in β-galactosyl ceramide. Treatment of cultures for 40 h with a potent analog of β-galactosyl ceramide (SNB-4050) produced significant decreases in CL granule area in the Cln3 ∆ex7/8 cultures; whereas identical studies on WT cultures produced no detectible changes. Significant decreases in average neurite length and neurite branch point number were also observed in the Cln3 ∆ex7/8 cultures that were attenuated by treatment with 1 nM SNB-4050. These studies indicate Cln3 ∆ex7/8 brain cultures may be useful to screen therapeutic agents for treatment of JBD.

Entities:  

Keywords:  Ceroid lipofuscin; Cln3 ∆ex7/8; High content analysis; Juvenile Batten disease; Mitochondrial ATP synthase subunit c; β-galactosyl ceramide

Mesh:

Substances:

Year:  2017        PMID: 28812237     DOI: 10.1007/s12031-017-0962-5

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

1.  Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].

Authors:  H M Mitchison; D J Bernard; N D Greene; J D Cooper; M A Junaid; R K Pullarkat; N de Vos; M H Breuning; J W Owens; W C Mobley; R M Gardiner; B D Lake; P E Taschner; R L Nussbaum
Journal:  Neurobiol Dis       Date:  1999-10       Impact factor: 5.996

2.  Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells.

Authors:  Yi Cao; John F Staropoli; Sunita Biswas; Janice A Espinola; Marcy E MacDonald; Jong-Min Lee; Susan L Cotman
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

3.  Isolation of a novel gene underlying Batten disease, CLN3. The International Batten Disease Consortium.

Authors: 
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

4.  Selective labeling of embryonic neurons cultured on astrocyte monolayers with 5(6)-carboxyfluorescein diacetate (CFDA).

Authors:  R E Petroski; H M Geller
Journal:  J Neurosci Methods       Date:  1994-04       Impact factor: 2.390

5.  Nerve conduction velocity measurements reveal the functional deficit in ceramide galactosyl transferase-deficient (cgt-/-) mice.

Authors:  Walter F Haupt; Wilhelm Stoffel
Journal:  J Neurol Sci       Date:  2004-01-15       Impact factor: 3.181

Review 6.  Current state of clinical and morphological features in human NCL.

Authors:  Hans H Goebel; Krystyna E Wisniewski
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

7.  CLN3p impacts galactosylceramide transport, raft morphology, and lipid content.

Authors:  Elena Rusyn; Talal Mousallem; Dixie-Ann Persaud-Sawin; Sara Miller; Rose-Mary N Boustany
Journal:  Pediatr Res       Date:  2008-06       Impact factor: 3.756

8.  Neurodevelopmental delay in the Cln3Deltaex7/8 mouse model for Batten disease.

Authors:  N S Osório; B Sampaio-Marques; C-H Chan; P Oliveira; D A Pearce; N Sousa; F Rodrigues
Journal:  Genes Brain Behav       Date:  2009-02-19       Impact factor: 3.449

9.  The Batten disease gene CLN3 is required for the response to oxidative stress.

Authors:  Richard I Tuxworth; Haiyang Chen; Valerie Vivancos; Nancy Carvajal; Xun Huang; Guy Tear
Journal:  Hum Mol Genet       Date:  2011-03-03       Impact factor: 6.150

10.  Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Elisa Fossale; Pavlina Wolf; Janice A Espinola; Tanya Lubicz-Nawrocka; Allison M Teed; Hanlin Gao; Dorotea Rigamonti; Elena Cattaneo; Marcy E MacDonald; Susan L Cotman
Journal:  BMC Neurosci       Date:  2004-12-10       Impact factor: 3.288

View more
  1 in total

1.  Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulation.

Authors:  Rebecca C Ahrens-Nicklas; Luis Tecedor; Arron F Hall; Owen Kane; Richard J Chung; Elena Lysenko; Eric D Marsh; Colleen S Stein; Beverly L Davidson
Journal:  Mol Ther       Date:  2022-04-05       Impact factor: 12.910

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.